Anna Maestroni

2.4k total citations
32 papers, 756 citations indexed

About

Anna Maestroni is a scholar working on Molecular Biology, Surgery and Ophthalmology. According to data from OpenAlex, Anna Maestroni has authored 32 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Surgery and 6 papers in Ophthalmology. Recurrent topics in Anna Maestroni's work include Pancreatic function and diabetes (9 papers), Retinal Diseases and Treatments (6 papers) and Chronic Kidney Disease and Diabetes (5 papers). Anna Maestroni is often cited by papers focused on Pancreatic function and diabetes (9 papers), Retinal Diseases and Treatments (6 papers) and Chronic Kidney Disease and Diabetes (5 papers). Anna Maestroni collaborates with scholars based in Italy, United States and France. Anna Maestroni's co-authors include Gianpaolo Zerbini, Silvia Maestroni, Gemma Tremolada, Francesco Bandello, Paolo Fiorina, Moufida Ben Nasr, Rosangela Lattanzio, F. Guidobono, Isabella Villa and Alessandro Rubinacci and has published in prestigious journals such as Diabetes, Analytical Biochemistry and Journal of the American Society of Nephrology.

In The Last Decade

Anna Maestroni

32 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Maestroni Italy 15 256 206 133 109 92 32 756
Masatoshi Kuroki Japan 16 508 2.0× 234 1.1× 149 1.1× 81 0.7× 21 0.2× 28 1.2k
T. Ledet Denmark 15 229 0.9× 124 0.6× 183 1.4× 51 0.5× 54 0.6× 35 710
Lianghu Huang China 16 429 1.7× 290 1.4× 96 0.7× 107 1.0× 41 0.4× 36 874
Yun Yan United States 18 379 1.5× 124 0.6× 81 0.6× 64 0.6× 12 0.1× 57 858
Ewa Pius‐Sadowska Poland 18 257 1.0× 105 0.5× 53 0.4× 51 0.5× 14 0.2× 53 828
Xiao Lin China 26 1.1k 4.3× 131 0.6× 105 0.8× 87 0.8× 193 2.1× 64 1.7k
Karen Keough United States 10 364 1.4× 52 0.3× 96 0.7× 73 0.7× 53 0.6× 16 878
Shigefumi Nakamura Japan 13 307 1.2× 345 1.7× 72 0.5× 31 0.3× 28 0.3× 15 762
Lorraine Rose United Kingdom 12 385 1.5× 182 0.9× 205 1.5× 55 0.5× 10 0.1× 22 840
Elisa Boscaro Italy 19 576 2.3× 253 1.2× 377 2.8× 74 0.7× 42 0.5× 33 1.5k

Countries citing papers authored by Anna Maestroni

Since Specialization
Citations

This map shows the geographic impact of Anna Maestroni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Maestroni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Maestroni more than expected).

Fields of papers citing papers by Anna Maestroni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Maestroni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Maestroni. The network helps show where Anna Maestroni may publish in the future.

Co-authorship network of co-authors of Anna Maestroni

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Maestroni. A scholar is included among the top collaborators of Anna Maestroni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Maestroni. Anna Maestroni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
D’Addio, Francesca, Emma Assi, Anna Maestroni, et al.. (2024). TMEM219 regulates the transcription factor expression and proliferation of beta cells. Frontiers in Endocrinology. 15. 1306127–1306127. 5 indexed citations
2.
Sabiu, Gianmarco, Emma Assi, Anna Maestroni, et al.. (2023). Broadening horizons in mechanisms, management, and treatment of diabetic kidney disease. Pharmacological Research. 190. 106710–106710. 29 indexed citations
3.
Assi, Emma, Francesca D’Addio, Chiara Mandò, et al.. (2020). Placental proteome abnormalities in women with gestational diabetes and large-for-gestational-age newborns. BMJ Open Diabetes Research & Care. 8(2). e001586–e001586. 23 indexed citations
4.
Nasr, Moufida Ben, Sara Tezza, Francesca D’Addio, et al.. (2017). PD-L1 genetic overexpression or pharmacological restoration in hematopoietic stem and progenitor cells reverses autoimmune diabetes. Science Translational Medicine. 9(416). 101 indexed citations
5.
Paterniti, Irene, Rosanna Di Paola, Michela Campolo, et al.. (2015). Palmitoylethanolamide treatment reduces retinal inflammation in streptozotocin-induced diabetic rats. European Journal of Pharmacology. 769. 313–323. 35 indexed citations
6.
Tezza, Sara, Moufida Ben Nasr, Andrea Vergani, et al.. (2014). Novel immunological strategies for islet transplantation. Pharmacological Research. 98. 69–75. 19 indexed citations
7.
Maestroni, Anna, et al.. (2014). ENDOTHELIAL PROGENITOR CELLS AND RESPONSE TO RANIBIZUMAB IN AGE-RELATED MACULAR DEGENERATION. Retina. 34(9). 1802–1810. 11 indexed citations
8.
Hyvönen, Mervi E., Pekka Ihalmo, Niina Sandholm, et al.. (2013). CD2AP is associated with end-stage renal disease in patients with type 1 diabetes. Acta Diabetologica. 50(6). 887–897. 8 indexed citations
9.
Rossi, Paolo, et al.. (2011). A Spontaneous Decrease of Blood Pressure Occurs in Acute Ischemic Stroke with Favourable Neurological Course. The Open Neurology Journal. 5(1). 48–54. 7 indexed citations
10.
Petrelli, Alessandra, Anna Maestroni, Gian Paolo Fadini, et al.. (2010). Improved Function of Circulating Angiogenic Cells Is Evident in Type 1 Diabetic Islet-Transplanted Patients. American Journal of Transplantation. 10(12). 2690–2700. 22 indexed citations
11.
Torgano, Giuseppe, Valter Monzani, Anna Maestroni, et al.. (2010). Effect of Intravenous Tirofiban and Aspirin in Reducing Short-Term and Long-Term Neurologic Deficit in Patients with Ischemic Stroke: A Double-Blind Randomized Trial. Cerebrovascular Diseases. 29(3). 275–281. 45 indexed citations
12.
Zerbini, Gianpaolo, et al.. (2007). Early renal dysfunctions in type 1 diabetes and pathogenesis of diabetic nephropathy. Journal of Nephrology. 20(S12). S19–S22. 8 indexed citations
13.
Zerbini, Gianpaolo, Lorenzo Piemonti, Anna Maestroni, Giacomo DellʼAntonio, & Giuseppe Bianchi. (2006). Stem Cells and the Kidney. Journal of the American Society of Nephrology. 17(4_suppl_2). S123–S126. 23 indexed citations
14.
Zerbini, Gianpaolo, et al.. (2006). Dysfunction of Cellular Transporters and Predisposition to Diabetic Nephropathy. Current Diabetes Reviews. 2(2). 163–168. 1 indexed citations
15.
Bo, Roberto Del, Marina Scarlato, Serena Ghezzi, et al.. (2006). VEGF gene variability and type 1 diabetes: evidence for a protective role. Immunogenetics. 58(2-3). 107–112. 31 indexed citations
16.
Maestroni, Anna, et al.. (2005). C-peptide increases the expression of vasopressin-activated calcium-mobilizing receptor gene through a G protein-dependent pathway. European Journal of Endocrinology. 152(1). 135–141. 11 indexed citations
17.
Zagato, Laura, Rita Paroni, Isabella Fermo, et al.. (2005). Direct assessment of angiotensin-converting enzyme activity on the surface of human skin fibroblasts in culture. Analytical Biochemistry. 338(2). 344–346. 2 indexed citations
18.
Zerbini, Gianpaolo, et al.. (2004). Increased Sodium-Lithium Countertransport Activity. Journal of the American Society of Nephrology. 15(1_suppl). S81–S84. 13 indexed citations
19.
Zerbini, Gianpaolo, Anna Maestroni, Diego Breviario, Ruggero Mangili, & Giorgio Casari. (2003). Alternative Splicing of NHE-1 Mediates Na-Li Countertransport and Associates With Activity Rate. Diabetes. 52(6). 1511–1518. 18 indexed citations
20.
Podestà, F, et al.. (2001). Low Ca2+ pump activity in diabetic nephropathy. American Journal of Kidney Diseases. 38(3). 465–472. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masatoshi Kuroki Breakdown of academic impact, for papers by T. Ledet Breakdown of academic impact, for papers by Lianghu Huang Breakdown of academic impact, for papers by Yun Yan Breakdown of academic impact, for papers by Ewa Pius‐Sadowska Breakdown of academic impact, for papers by Xiao Lin Breakdown of academic impact, for papers by Karen Keough Breakdown of academic impact, for papers by Shigefumi Nakamura Breakdown of academic impact, for papers by Lorraine Rose Breakdown of academic impact, for papers by Elisa Boscaro
Rankless by CCL
2026